4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-19-054525
10% owner bought 1,052,631 shares at $19.00 ($19,999,989)
- 10% owner acquired 1,353,640 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Frazier Life Sciences IX, L.P. 10% owner | 2019-10-29 | Conversion | +1,353,640 | $15.20 | $20,575,328 | 6,231,638 | D |
| Frazier Life Sciences IX, L.P. 10% owner | 2019-10-29 | Purchase | +1,052,631 | $19.00 | $19,999,989 | 7,284,269 | D |
| Derivatives | |||||||
| Frazier Life Sciences IX, L.P. 10% owner | 2019-10-29 | Conversion · Convertible Promissory Notes | −0 | 0 | D | ||
| Open-market purchases · 1,052,631 sh · avg $19.00 · $19,999,989 | |||||||
Loading xslF345X03/doc4.xml…